Mesenchymal stem cells secretome as a prospective therapeutic option for COVID-19 patients
Posted: 13 April 2020 | Avinash Kharat (Dr D Y Patil Vidyapeeth), Avinash Sanap ( Dr D Y Patil Vidyapeeth), Dr Ramesh Bhonde (Dr D Y Patil Vidyapeeth), Supriya Kheur (Dr D Y Patil Vidyapeeth) | 1 comment
Researchers propose using mesenchymal stem cells to counter the pro-inflammatory cytokines associated with COVID-19 coronavirus symptoms.
To read the research, click here.
With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit:
Related topics
Drug Targets, Research & Development, Stem Cells, Therapeutics
Related conditions
Coronavirus, Covid-19
Spike Protein act as the mechanical oscillators and when the coupling between S1 of COVID 19 and ACET of host cell can occur, their frequencies are close to gether.
If the bunch of COVID-19 can be formed with new frequency, in this case, individual COVID 19 cann’t interact with host cell.
I think the generation of bunch of COVID -19 is possible.